Skip to search formSkip to main contentSkip to account menu

Loteprednol

Known as: Loteprednolum 
National Institutes of Health

Related topics

Related topics

13 relations
Allergic ConjunctivitisBacterial conjunctivitisDrug AllergyEdema

Narrower (1)

loteprednol etabonate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Notes from the Field: Conjunctivitis Caused by Toxigenic Corynebacterium ulcerans — Missouri, 2018
On December 12, 2018, an immunocompromised man with non-Hodgkin’s lymphoma, aged 73 years, was evaluated by an ophthalmologist… 
2018
2018
Intraocular Pressure after Myopic Photorefractive Keratectomy
© 2018 Journal of ophthalmic and Vision research | published by Wolters KluWer medKnoW © 2018 Journal of ophthalmic and Vision… 
2016
2016
Elevated Intraocular Pressure and Endothelial Cell Loss Following Iris Color Change.
Amaninhis30spresentedwithcomplaintsofbilateralblurryvision,eye redness, andheadaches. His ocular history was significant for… 
2014
2014
Efficacy of tobramycin dexamethasone combined with loteprednol in thetreatment of anterior uveitis and its impact on serum IgG, IgA, and IgE.
Objective of the present study is to investigate the efficacy of tobramycin dexamethasone combined with loteprednol for the… 
2010
2010
Post-ocular surgery, loteprednol delivers pain relief
A post hoc analysis of data collected in two published, pivotal clinical trials demonstrates that in addition to its efficacy for… 
Review
2006
Review
2006
Can corticosteroids be beaten in future asthma therapy?
Despite the enormous therapeutic advance, there is a general trend towards increasing morbidity and mortality due to asthma… 
2003
2003
Safety and efficacy of loteprednol for ocular inflammation: a meta-analysis
AIM: To evaluate the safety and efficacy of loteprednol for controlling of ocular inflammation. METHODS: Data from 8 relevant… 
2000
2000
New combination of loteprednol and antihistamines products.
Pharmaceutical mixture comprising loteprednol or a pharmaceutically acceptable ester thereof and at least one antihistamine. 
1999
1999
Effect of AWD 12-281, a new selective PDE4-inhibitor, loteprednol and beclomethasone in models of allergic rhinitis and airway inflammation in brown Norway-rats
1999
1999
New combination of loteprednol and beta¶2¶-adrenoceptor agonists
The invention relates to a novel combination of a soft steroid, especially loteprednol, and at least one beta 2-adrenoceptor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)